Insider Transactions in Q2 2022 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2022
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-1.49%
|
$47,808
$83.92 P/Share
|
|
Jun 03
2022
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,021
-12.98%
|
$540,617
$77.49 P/Share
|
|
May 26
2022
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,308
-2.36%
|
$102,024
$78.94 P/Share
|
|
May 24
2022
|
Mark J Alles Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+40.62%
|
-
|
|
May 24
2022
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+20.86%
|
-
|
|
May 24
2022
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+17.55%
|
-
|
|
May 24
2022
|
Elaine J Heron Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+5.5%
|
-
|
|
May 24
2022
|
Maykin Ho Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+28.57%
|
-
|
|
May 24
2022
|
Robert J. Hombach Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+15.92%
|
-
|
|
May 24
2022
|
V Bryan Lawlis Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+14.68%
|
-
|
|
May 24
2022
|
Richard A Meier Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+4.37%
|
-
|
|
May 24
2022
|
David E I Pyott Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+10.87%
|
-
|
|
May 24
2022
|
Dennis Slamon Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,980
+15.76%
|
-
|
|
May 16
2022
|
Erin Burkhart GVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,130
+50.0%
|
-
|
|
May 06
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
20,000
-5.63%
|
$1,620,000
$81.0 P/Share
|
|
May 06
2022
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.33%
|
$740,000
$37.46 P/Share
|
|
May 05
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.9%
|
$840,000
$84.14 P/Share
|
|
May 05
2022
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.81%
|
$370,000
$37.46 P/Share
|
|
May 04
2022
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,800
-12.59%
|
$991,200
$84.5 P/Share
|
|
May 04
2022
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,800
+10.78%
|
$436,600
$37.46 P/Share
|
|
May 04
2022
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,926
-7.51%
|
$329,784
$84.65 P/Share
|
|
May 02
2022
|
Richard A Meier Director |
SELL
Open market or private sale
|
Direct |
3,878
-1.8%
|
$317,996
$82.1 P/Share
|
|
May 02
2022
|
Richard A Meier Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+7.3%
|
$314,500
$37.46 P/Share
|
|
May 02
2022
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,347
-18.79%
|
$1,227,760
$80.38 P/Share
|
|
May 02
2022
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,347
+15.82%
|
$567,839
$37.46 P/Share
|
|
Apr 29
2022
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
340
+0.61%
|
$21,080
$62.41 P/Share
|
|
Apr 29
2022
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
341
+0.1%
|
$21,142
$62.41 P/Share
|
|
Apr 29
2022
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
340
+0.87%
|
$21,080
$62.41 P/Share
|
|
Apr 29
2022
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
243
+0.46%
|
$15,066
$62.41 P/Share
|
|
Apr 29
2022
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
341
+0.51%
|
$21,142
$62.41 P/Share
|
|
Apr 29
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.47%
|
$405,000
$81.95 P/Share
|
|
Apr 29
2022
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.45%
|
$185,000
$37.46 P/Share
|
|
Apr 28
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
20,000
-5.63%
|
$1,660,000
$83.79 P/Share
|
|
Apr 28
2022
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.33%
|
$740,000
$37.46 P/Share
|
|
Apr 25
2022
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,669
+3.89%
|
$98,753
$37.46 P/Share
|
|
Apr 18
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
20,000
-5.63%
|
$1,620,000
$81.91 P/Share
|
|
Apr 18
2022
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.33%
|
$740,000
$37.46 P/Share
|
|
Apr 14
2022
|
V Bryan Lawlis Director |
SELL
Open market or private sale
|
Direct |
4,250
-15.06%
|
$352,750
$83.66 P/Share
|
|
Apr 14
2022
|
V Bryan Lawlis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+13.09%
|
$157,250
$37.46 P/Share
|
|
Apr 14
2022
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.9%
|
$830,000
$83.66 P/Share
|
|
Apr 14
2022
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.82%
|
$370,000
$37.46 P/Share
|
|
Apr 13
2022
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,180
-2.1%
|
$96,760
$82.47 P/Share
|